Thermo Fisher Scientific Inc. (TMO) Stock Analysis

Thermo Fisher Scientific (TMO) is a global leader in life-science tools, diagnostics, and laboratory services with **>$45B** in annual revenue and a business model built to maximize recurring revenue. It operates across four segments—**Laboratory Products & Biopharma Services (~55%)**, **Life Sciences Solutions (~24%)**, **Analytical Instruments (~16%)**, and **Specialty Diagnostics (~10%)**—serving pharma/biotech, academia, governments, and clinical labs. A core differentiator is its **“razor-and-blade”** structure: high-end instruments (e.g., mass specs, electron microscopes) anchor workflows that pull through repeat consumables and service contracts. Geographic exposure is led by North America (~52%), then Europe (26%) and APAC (18%) with notable China sensitivity. Thermo’s scale, distribution power (Fisher Scientific), and PPI operating system create deep switching costs and a durable “trusted partner” ecosystem, increasingly extended into CRO/CDMO services and clinical trial data.